Searle Scholars Program 2027: $450,000 Over Three Years of Unrestricted Research Support for 15 First-Year Assistant Professors in Biomedical Science and Chemistry

Searle Scholars Program 2027: $450,000 Over Three Years of Unrestricted Research Support for 15 First-Year Assistant Professors in Biomedical Science and Chemistry

The first two years of a tenure-track appointment are the hardest years to fund. Startup packages run out faster than anyone plans for, federal study sections want preliminary data that a brand-new lab has not had time to generate, and the most interesting ideas — the ones that made a department want to hire you in the first place — are usually the ones with the least evidence behind them. The Searle Scholars Program exists precisely for that gap. It gives 15 newly appointed assistant professors a year $450,000 over three years, paid at $150,000 annually, to support the research described in their application, and it selects on the basis of long-term potential rather than accumulated preliminary results.

For the 2027 competition, nominations opened to participating institutions on June 1, 2026, and applications are due September 30, 2026. Awards activate on July 1, 2027. This is a limited-submission program: only candidates nominated by an institution already invited into the program can apply, and access to the online application is shared only with nominated applicants. That single fact shapes almost everything about how you should approach it — the real competition often happens inside your own university, months before the national deadline.

This guide covers what the award provides, exactly who is eligible, how the nomination and selection process works, what the Scientific Advisory Board is actually looking for, and how to prepare if you are eligible for the 2027 round or planning for a future one.

Key Details at a Glance

What the Award Actually Provides

The grant is set at $450,000 across a three-year period. The structure is deliberately simple: $150,000 in the first year, and equal sums in the second and third years, with continuation contingent on the Program receiving acceptable progress reports. There is no complicated milestone schedule and no requirement to renegotiate the budget annually.

Awards are made to tax-exempt institutions described in section 501(c)(3) of the Internal Revenue Code, not to individuals, and the funds are designated for the support of the research described in the application. In practice this means the money follows a program of research rather than a narrowly scoped set of aims, which is why Searle Scholars frequently describe the award as buying intellectual freedom rather than paying for a single experiment.

Two features make the award unusually valuable at this career stage. First, the Program places no restrictions on receiving or applying for other funding — it explicitly describes the award as meant to supplement other support an investigator receives. You do not have to choose between a Searle award and an NIH R01, a DoD grant, or another private foundation award. Second, the selection criteria reward the kind of ambitious, unproven direction that federal panels tend to discount. That combination is why the award is often used to launch the risky arm of a new lab’s portfolio while conventional grants cover the safer arm.

Beyond the money, Scholars join a cohort. Searle Scholars are expected to attend the Annual Searle Scholars Meeting, normally held in Chicago in April, and to submit a scientific abstract and headshot ahead of it. The Scientific Advisory Board itself includes many former Searle Scholars, and the annual meeting is one of the few settings where a first-year assistant professor presents alongside two generations of investigators who received the same award. The Program has been investing in early-career scientists since 1980.

Who Is Eligible

The eligibility rules are narrow and specific, and the timing rule is the one that disqualifies the most people.

Career stage and appointment date. Applicants for the 2027 competition should have begun their appointment as an independent investigator at the assistant professor level on or after May 1, 2025. The appointment must be their first tenure-track position, or its nearest equivalent. This is a rolling window: each competition year moves the earliest eligible start date forward, so an investigator is typically eligible for one or two cycles at most.

Institutions without tenure tracks. Research institutes and other organizations that do not have tenure-track appointments should consult the Scientific Director of the Program about the eligibility of selected applicants before nominating them. Do not assume an equivalent title qualifies — confirm it first.

Research field. Applicants are expected to be pursuing independent research careers in biochemistry, cell biology, genetics, immunology, neuroscience, pharmacology, and related areas in chemistry, medicine, and the biological sciences. The Program does not ordinarily support purely clinical research, though it has supported programs that include both clinical and basic components. If you are unsure whether your work fits, the Program encourages you to examine the research interests of present and former Searle Scholars listed on its website — that catalogue is the most honest guide to the boundaries of scope, better than any abstract description of eligible fields.

Degree. Basic biological scientists who hold only an M.D. are eligible, provided they are researchers rather than purely clinicians and their research contains basic science components.

Citizenship and employment. U.S. citizenship is not required. However, awardees must be legally employed at a United States degree-granting or research institution, and awards are made only to 501(c)(3) tax-exempt institutions that participate in the Program.

Nomination. Submissions are restricted to selected candidates from participating institutions only. Individuals who have not been nominated by a participating institution cannot apply, and the application link is shared only with nominated applicants.

Renomination. Applicants who were nominated in the previous competition year but were not awarded may still meet the criteria for the current competition. Institutions should consult the Scientific Director about renominating such individuals — worth knowing if you were nominated for 2026 and did not receive an award.

Exceptions to the start date. The Program does consider extenuating circumstances and may make exceptions case by case. It lists favorable considerations explicitly: a start date very close to the stated date, an unusually short period of postdoctoral training, and parental leave. If any of those apply to you, contact the Scientific Director rather than assuming you are out of the running.

How the Nomination Process Works

This is where most eligible scientists lose the opportunity without ever seeing an application form.

On June 1, 2026, the Program sent letters of invitation and online nomination instructions to participating institutions. Each institution then runs its own internal limited-submission competition to decide who it will put forward. Only after a nomination is placed does the online application become available to the selected individual.

If you are at a participating institution, the person you need to find is the official who handles limited submission awards — typically in an office of research development, corporate and foundation relations, or the vice president for research’s office. The Program publishes a participating institutions list with a named contact at each one; it spans large public universities, private research universities, medical schools, and independent research institutes such as the Allen Institute, the Broad Institute, and the Buck Institute for Research on Aging.

Internal deadlines at these institutions commonly fall months before the national September 30 deadline — often in the early summer, sometimes in spring. If you are reading this in late July 2026 and have not spoken to your limited-submission office, that conversation is the single most urgent action available to you. Ask two questions: whether your institution has already selected its 2027 nominee, and what the internal process and timeline will be for the 2028 competition.

If your institution is not on the list. The Program is a limited submission process, and applicants may only apply if nominated by an invited institution. Institutions that are not currently invited may send a one-to-two-page letter of appeal requesting inclusion, signed by an appropriate institutional official. The letter should include contact information with an email address for the response, an overview of the institution — especially its biomedical and chemistry research departments — and any significant plans for expansion of research faculty, addition of new facilities, or other enhancements to the research community. In reviewing an appeal, the Program will also explore information available on departmental websites. Appeals are considered once a year and must arrive by February 1 for consideration in the next competition, addressed to:

Scientific Advisory Board Searle Scholars Program P.O. Box 1707 Madison, Wisconsin 53701

or emailed to [email protected].

This is a real route, not a formality, but it operates on institutional timescales. If your department chair or research office is willing to pursue it, the February 1 deadline means the earliest realistic effect is on a competition cycle at least a year out.

How Applications Are Judged

The Program states its priority plainly: the Scientific Advisory Board is primarily interested in the potential of applicants to make innovative and high-impact contributions to research over an extended period of time. The Board is composed of experts in the fields of interest to the Program, many of them former Searle Scholars, and the Program describes its aim as finding creative, innovative, and “high risk/high reward” research.

Read that carefully, because it changes what a strong application looks like. Three implications matter:

The unit of assessment is you, not a project. “Potential to make contributions over an extended period” is a statement about a research career. Reviewers are trying to decide whether your lab, five and ten years from now, will have changed how people in your field think. A proposal that reads as a competent three-year work plan can score worse than one that reads as the opening move of a distinctive long-term program.

Preliminary data is not the currency. The eligibility window guarantees that every applicant is at most about 17 months into an independent appointment when applications close. The Board knows this. It cannot be selecting on volume of new-lab data, because almost nobody has much. It is selecting on the quality of the idea, the credibility of the approach, and the evidence — from your training record and your reasoning — that you are the person who can execute it.

“High risk/high reward” is meant literally. A proposal whose worst case is a modest incremental result is not what the phrase describes. The Board is looking for work where success would be genuinely consequential, and where failure is a live possibility. Articulating the risk directly, and explaining why you are equipped to manage it, is more persuasive than hiding it.

Applications are screened by the Scientific Advisory Board over the review period from October 1, 2026 through March 2027, the Board meets in March 2027, and all applicants are notified of results by the end of April of the award year.

Preparing a Competitive Application

Because the application system opens only to nominated candidates, the specific required components are shared with you at that point. What follows is guidance on substance, which is where the decision is made.

Write the vision before you write the aims. Draft a single paragraph that states what your lab will be known for. If you cannot write it without listing techniques, the underlying program is not yet sharp enough. Everything else in the application should visibly serve that paragraph.

Make the risk legible and bounded. Reviewers evaluating high-risk work want to see that you understand exactly which assumption the project rests on and what you will do if it fails. A short, honest passage identifying the critical uncertainty and your contingency reads as competence, not weakness.

Use your training record as evidence of capability, not as a list. The strongest signal you can send is a demonstrated ability to see something others missed and follow it through. Where your postdoctoral or graduate work shows that, say so explicitly rather than leaving reviewers to infer it from a publication list.

Explain how this award changes the trajectory. Since Searle funds supplement other support, be clear about what the $450,000 makes possible that your startup package and other pending grants do not. That contrast is one of the easiest ways to show that the money will produce something that would not otherwise exist.

Write for a broad expert panel. The Board spans biochemistry through neuroscience and chemistry. Your reviewers will be excellent scientists who are not in your subfield. Define your terms, motivate the problem in terms a colleague two departments over would find compelling, and do not rely on subfield shorthand.

Give your internal reviewers real time. At most institutions, the internal limited-submission committee sees a short pre-proposal months before the national deadline. That committee decides whether you apply at all. Treat it as the first round of the competition and prepare for it with the same seriousness.

Common Mistakes

Discovering the program after the internal deadline. The most frequent failure mode has nothing to do with the quality of anyone’s science. Newly hired assistant professors are busy setting up labs and often learn about limited-submission awards only when the internal call has already closed. Add the Searle cycle to your calendar the month you start your appointment.

Assuming eligibility rather than confirming it. Two situations in particular need a direct conversation with the Scientific Director before nomination: appointments at institutions without a tenure track, and start dates slightly outside the stated window where parental leave, a short postdoc, or a near-miss date might justify an exception.

Proposing purely clinical research. The Program does not ordinarily support it. Research programs combining clinical and basic components have been supported, but the basic science must be substantive and central, not decorative.

Submitting a scaled-down R01. An application built around safe, well-hedged aims with abundant preliminary data is a good federal proposal and a mediocre Searle application. The selection criteria point in a different direction.

Treating a prior unsuccessful nomination as final. If you were nominated for the previous competition and not awarded, you may still be eligible. Your institution should consult the Scientific Director about renomination rather than assuming the door is closed.

Ignoring the reporting commitments. Continuation payments in years two and three are subject to acceptable progress reports, institutions must file annual fiscal reports requested in July and due in August, and final scientific and fiscal reports are due within 60 days of award termination. Publications arising from supported work should acknowledge funding from the “Searle Scholars Program.” Confirm early who in your department will own these obligations.

Frequently Asked Questions

Can I apply directly? No. You must be nominated by a participating institution. Consult the institutional official designated for your institution on the participating institutions list.

Are there restrictions on holding other funding? No. The Program does not place any restrictions on funding from other sources; the award is meant to supplement other support an investigator receives.

Do I need to be a U.S. citizen? No. But awardees must be legally employed at a U.S. degree-granting or research institution, and awards go to participating 501(c)(3) institutions rather than to individuals.

I hold an M.D. rather than a Ph.D. Am I eligible? Yes, as long as you are a researcher rather than a purely clinical practitioner and your research contains basic science components.

My appointment started slightly before May 1, 2025. Is that automatically disqualifying? Not necessarily. The Program considers extenuating circumstances case by case, and specifically names a start date very close to the stated date, an unusually short postdoctoral period, and parental leave as favorable considerations. Contact the Scientific Director.

My institution is not a participating institution. You cannot apply this cycle. Your institution may submit a letter of appeal for inclusion by February 1 for consideration in the next competition.

How many awards are made? Generally 15 new awards annually.

When will I hear? All applicants are notified of competition results by the end of April of the award year — end of April 2027 for the 2027 competition.

Timeline for the 2027 Competition

• June 1, 2026 — Letters of invitation and online nomination instructions sent to participating institutions; nomination opens.
• Summer 2026 — Internal limited-submission competitions run at participating institutions; internal deadlines vary and are frequently well before the national deadline.
• September 30, 2026 — Applications due, submitted online. This is also the due date for progress reports from current Scholars.
• October 1, 2026 – March 2027 — Review period.
• March 2027 — Scientific Advisory Board meets to select the class.
• By end of April 2027 — All applicants notified of results.
• April 2027 — Annual Searle Scholars Meeting, normally in Chicago.
• July 1, 2027 — Awards activate for the 2027 class of Searle Scholars.

Next Steps

If you started your first tenure-track assistant professorship on or after May 1, 2025 and work in the biomedical sciences or chemistry, do three things this week.

First, check whether your institution appears on the participating institutions list and identify the named contact there.

Second, email that contact to ask whether the 2027 nomination has already been made and what the process and internal timeline will be for the next cycle. If the 2027 slot is still open, ask what they need from you and by when.

Third, read through the research interests of current and former Searle Scholars on the Program’s website. It is the clearest available picture of what the Scientific Advisory Board has actually chosen to fund, and it will tell you quickly whether your program sits inside the Program’s scope or at its edge.

If you have questions about the scientific fit of a potential application or about eligibility, those go to the Scientific Director; other questions go to Kinship Foundation staff, via the contact details on the Program’s website. If your institution is not currently invited to participate, raise the February 1 appeal route with your research office now, since it affects a future competition rather than this one.

Official Links

• Process and Eligibility: https://searlescholars.org/application-information/award-information/process-and-eligibility/
• Award Information: https://searlescholars.org/application-information/award-information/
• Award Cycle Dates: https://searlescholars.org/application-information/award-cycle-dates/
• Participating Institutions: https://searlescholars.org/application-information/participating-institutions/
• Program home page: https://searlescholars.org/
• General enquiries: [email protected]

All amounts, dates, and eligibility conditions in this guide come from the Searle Scholars Program’s own published pages as of July 26, 2026. Internal nomination deadlines are set by each participating institution and are not published centrally — confirm yours with your institutional contact.